What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Chagas disease, Trypanosoma cruzi, Pharmacology, Immunology and Biochemistry.
His Chagas disease research incorporates elements of Trypanosomiasis, Benznidazole, Chemotherapy and Nifurtimox.
His research in Trypanosoma cruzi focuses on subjects like Biological activity, which are connected to Nuclear chemistry and Plasmodium falciparum.
His study connects In vivo and Pharmacology.
The various areas that Julio A. Urbina examines in his Immunology study include Parasitic disease and Disease.
He has included themes like Ultrastructure and Amastigote in his Biochemistry study.
His most cited work include:
- Specific chemotherapy of Chagas disease: controversies and advances. (473 citations)
- Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. (347 citations)
- Chemotherapy of trypanosomiases and leishmaniasis (322 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Biochemistry, Trypanosoma cruzi, Chagas disease, Sterol and Amastigote.
His work on Enzyme, Ergosterol and Squalene as part of general Biochemistry research is often related to Ketoconazole and Farnesyl-diphosphate farnesyltransferase, thus linking different fields of science.
The study incorporates disciplines such as Biological activity, In vivo and Trypanosoma in addition to Trypanosoma cruzi.
His studies in Chagas disease integrate themes in fields like Trypanosomiasis, Benznidazole and Pharmacology.
As a member of one scientific family, Julio A. Urbina mostly works in the field of Sterol, focusing on Phospholipid and, on occasion, Fatty acid.
His Amastigote course of study focuses on Intracellular and Endoplasmic reticulum.
He most often published in these fields:
- Biochemistry (53.90%)
- Trypanosoma cruzi (43.26%)
- Chagas disease (31.91%)
What were the highlights of his more recent work (between 2012-2020)?
- Chagas disease (31.91%)
- Pharmacology (19.86%)
- Benznidazole (14.18%)
In recent papers he was focusing on the following fields of study:
Julio A. Urbina mostly deals with Chagas disease, Pharmacology, Benznidazole, Posaconazole and Trypanosoma cruzi.
Chagas disease is the subject of his research, which falls under Immunology.
His research integrates issues of Parasitic disease and Disease in his study of Immunology.
His work carried out in the field of Pharmacology brings together such families of science as Amastigote, Biochemistry, Adult patients, Antifungal drug and Trypanocidal agent.
His Benznidazole research includes themes of Pharmacokinetics, Clinical trial, Therapeutic index, Nifurtimox and Pharmacotherapy.
His biological study spans a wide range of topics, including Cell culture, Genetically engineered, Fibrosis, Cardiac fibrosis and Western blot.
Between 2012 and 2020, his most popular works were:
- Recent Clinical Trials for the Etiological Treatment of Chronic Chagas Disease: Advances, Challenges and Perspectives (104 citations)
- Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments (82 citations)
- Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region (61 citations)
In his most recent research, the most cited papers focused on:
Julio A. Urbina mostly deals with Chagas disease, Posaconazole, Benznidazole, Pathology and Family medicine.
Chagas disease is a subfield of Immunology that he explores.
Other disciplines of study, such as Pentamidine, Leishmania, Ergosterol, Microbiology and Leishmaniasis, are mixed together with his Posaconazole studies.
His Benznidazole research integrates issues from Pharmacotherapy, Combination therapy, Drug, Pharmacology and Parasitemia.
His work on Neglected tropical diseases as part of general Pathology study is frequently linked to Declaration, therefore connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
